CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr | ₹-18 Cr | ₹125 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-403 Cr |
Mar2023 | ₹-293 Cr |
Mar2022 | ₹-205 Cr |
Mar2021 | ₹-18 Cr |
Mar2020 | ₹125 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-403 Cr | Negative | |
Mar2023 | ₹-293 Cr | Negative | |
Mar2022 | ₹-205 Cr | Negative | |
Mar2021 | ₹-18 Cr | Negative | |
Mar2020 | ₹125 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹116,431.7 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -5.4% |
-1.5% |
0.8% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses